Contracts › 75A50325F80014
75A50325F80014: Oseltamivir Phosphate 75MG Capsules (Ndc: 76282-0704-45); 10 Ct. Blisters Packs and Oseltamivir Phosphate 30MG Capsules (Ndc: 76282-0702-45); 10 Ct. Blisters Packs.
Awarded to Exelan Pharmaceuticals Inc by Office of Assistant Secretary for Preparedness and Response.
$74.1Mobligated
$74.1Mpotential value
29 June 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50325F80014 |
|---|---|
| Vehicle | 36F79720D0227 |
| Awardee | Exelan Pharmaceuticals Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | ASPR/ORM-SNS |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | FL |
| Offers received | 3 |
| Period of performance | 28 June 2025 to 29 June 2027 |
| Potential end | 29 June 2027 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record